A South Korean research team has identified several clinical and medical factors associated with renal function decline in patients with chronic hepatitis B virus (HBV) infection treated with oral ...

Nutrition significantly impacts RCC development and treatment, affecting patient outcomes and stress management. Post-diagnosis, patients often modify diets, but face challenges like stress and ...

Patients with liver metastases, larger tumors, and elevated preoperative C-reactive protein are at higher risk for early recurrence after cytoreductive nephrectomy and complete metastasectomy.

VORSIN-RCC: Vorolanib plus sintilimab for advanced renal cell carcinoma after failure of prior immune checkpoint inhibitors-based combination therapy. Background: At diagnosis, 55% of RCC are ...

Cystic renal cell carcinoma is a rare type of cancer. A person may develop cystic renal cell carcinoma if they have treatment for the last stages of kidney failure. Cystic renal cell carcinoma (CRCC) ...

Cabozantinib plus nivolumab (C+N) versus sunitinib (S) in patients with advanced renal cell carcinoma (aRCC) and liver metastasis: Subgroup analysis of the phase 3 CheckMate-9ER trial. Emotional ...

A group of medical experts, including diabetologists, endocrinologists and cardiologists from across the country, have joined hands to develop a web app-based unified tool capable of simultaneously ...